Hyperbaric Oxygenation Therapy for Idiopathic Sudden Sensory Neural Hearing Loss

Experience of Use of PGE₁

Abstract

We analyzed statistically the prognosis of hearing impairment in patients with idiopathic sudden sensory neural hearing loss. 119 patients (SGB group) were treated with the combination therapy with hyperbaric oxygenation (HBO) and stellate ganglion block (SGB) as well as oral administration of vasodilator and vitamins. 39 patients (PG group) were treated with HBO and intravenous drip infusion of prostaglandin E₁ (PGE₁). As conclusion, the therapeutic results in PG group was worse than SGB group, but there was no statistical significance.